FEDERALhearing transcript

Congressional Hearing on FDA Cosmetic Safety Oversight

Original title: BUILDING CONSUMER CONFIDENCE BY EMPOWERING FDA TO IMPROVE COSMETIC SAFETY

January 1, 2022

cosmetic safety FDA regulation consumer protection public health H.R. 4296 H.R. 5279

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing explores potential new federal requirements for cosmetic manufacturers, which could change how products are tested, labeled, and reported to the FDA for safety.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Cosmetic Manufacturers

Proposed legislation could impose new safety testing, reporting, and labeling requirements on these businesses.

FDA

The agency may receive expanded regulatory authority and oversight responsibilities for the cosmetic industry.

Consumers

Changes in regulation could alter the safety information available on product labels and the oversight of ingredients used in personal care items.

What changed

Last recorded activity January 1, 2022.

What's next

Next step not available in the current record.

Summary

The House held a hearing on December 4, 2019, to discuss expanding the FDA's authority to regulate the safety of cosmetic and personal care products. Lawmakers and witnesses reviewed two proposed bills, H.R. 4296 and H.R. 5279, aimed at enhancing oversight in the beauty and personal care industry.

Key Facts

The hearing was held on December 4, 2019, by the House Subcommittee on Health.
The primary focus was the discussion of H.R. 4296 (Safe Cosmetics and Personal Care Products Act of 2019) and H.R. 5279 (Cosmetic Safety Enhancement Act of 2019).
The hearing included testimony from FDA officials, industry representatives, and public health advocacy groups.
Witnesses provided written testimony and responses to follow-up questions for the record.
The committee reviewed evidence regarding current FDA oversight capabilities for cosmetic products.
The hearing record includes a 2019 Reuters article regarding Johnson & Johnson's marketing practices for baby powder.

Why It Matters

This hearing explores potential new federal requirements for cosmetic manufacturers, which could change how products are tested, labeled, and reported to the FDA for safety.

Frequently Asked Questions

What is the purpose of this hearing?

The hearing was held to examine how the FDA can better regulate cosmetic safety and to discuss two specific bills proposing new safety standards.

Who testified at the hearing?

Witnesses included representatives from the FDA, the beauty industry, small-scale cosmetic producers, and public health advocacy organizations.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Increased Focus on Cosmetic Regulation

The hearing highlights a legislative push to modernize FDA oversight of cosmetics, an area that has historically had less stringent federal requirements than food or drugs.

FDA H.R. 4296 H.R. 5279

Connected Entities

personSusan T. Mayne“Director, Center for Food Safety and Applied Nutrition, FDA”Map →

organizationEnvironmental Working Group“Represented by witness Scott Faber”Map →

personMichael C. Burgess“Ranking Member of the Subcommittee on Health”Map →

organizationBeautycounter, LLC“Represented by witness S. Gregg Renfrew”Map →

organizationNational Women's Health Network“Represented by witness M. Isabelle Chaudry”Map →

organizationHandcrafted Soap and Cosmetic Guild“Represented by witness Leigh O'Donnell”Map →

personAnna G. Eshoo“Chairwoman of the Subcommittee on Health”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment20
Compellingness for a non-policy-wonk reader
Buzz25
Current news / social attention level

Publisher tools